期刊文献+

非霍奇金淋巴瘤患者T细胞亚群、NK细胞检测的临床意义 被引量:26

The clinical significance of peripheral blood T cell subsets,NK cells in NHL
下载PDF
导出
摘要 目的:研究非霍奇金淋巴瘤(NHL)患者外周血T淋巴细胞亚群、NK细胞检测结果的变化与该病的关系及与慢性淋巴腺炎患者细胞免疫功能的不同变化。方法:采用流式细胞仪(FCM)检测非霍奇金淋巴瘤(NHL)患者、慢性淋巴腺炎及正常人外周血T淋巴细胞亚群比例、NK细胞的变化。结果:非霍奇金淋巴瘤患者与正常人比较总的T淋巴细胞、辅助性T淋巴细胞及CD4+/CD8+比值明显下降(P<0.05),细胞毒性T淋巴细胞明显升高(P<0.05),NK细胞则无明显变化(P>0.05)。非霍奇金淋巴瘤患者与慢性淋巴腺炎患者比较,细胞毒性T淋巴细胞、NK细胞明显升高(P<0.05),而总的T淋巴细胞、辅助性T淋巴细胞无明显改变(P>0.05),CD4+/CD8+比值略有下降但无明显统计学意义。结论:非霍奇金淋巴瘤患者细胞免疫功能明显受到抑制,T细胞亚群及NK细胞的检测对NHL的诊断、治疗、预后判断有一定的临床价值。 Objective:To investigate the relationship of the changes of peripheral bloos T cell subsets and NK cell with nonHodgkin's lymphoma(NHL). And to investigate the change of the cell immune function of NHL and chronic lymphadenitis. Methods: Peripheral blood T cell subsets, NK cell with NHL,chmnic lymphadenitis patients and 50 normal controls were detected quantitatively with FCM. Results: Compared with the normal controls, the number of CD3 ^+ , CD4 ^+ T cell, CD4 ^+/CD8 ^+ ratio markedly reduced, while those of CD8 ^+ T cells increased. These were no significant changes in NK cell. Compared with the group of chrnic lymphadenitis, the number of CD8 ^+ T cell, NK cell markedly increased, while these were no significant changes in CD3 ^+ , CD4 ^+ T cell and reduction of CD4.^+/CD8 ^+ ratio. Concluslon:NHL patients cell function was suppressed. The detection of T cell subsets and NK cells are clinically valuble on the diagnosis,treatment and prognosis of NHL.
出处 《中国免疫学杂志》 CAS CSCD 北大核心 2006年第2期180-181,185,共3页 Chinese Journal of Immunology
关键词 非霍奇金淋巴瘤 T细胞亚群 NK细胞 流式细胞仪 NHL T cell subsets NK cell FCM
  • 相关文献

参考文献11

  • 1谭达人,谭齐贤,张树平 et al.白细胞检验的临床应用[M]第3版..临床血液学和血液检验.,2003.234.
  • 2Anmifage.Treatment of non-Hodgkin's lymphoma[J].N Eng J Med,1993;328(14):1023.
  • 3吕鸣,孔宪涛,李莉,张玲珍,施笑梅,黄隆安.流式细胞术分析非霍奇金淋巴瘤患者细胞免疫功能变化[J].上海医学,1997,20(2):73-75. 被引量:13
  • 4Tancini G,Baunis,Rescaldani R et al.Analysis of T helper and suppressor lymphocyte subsets in relation to the clinical stage of solid neplasms[J].Oncology,1990;47(5);381-384.
  • 5Khalil R Y,Khalil M M.Flow cytometric study of T-cell subsets in lymphocyte pleural effusions[J].Cytometry,1997;30(40):204-205.
  • 6Tbakhi A,Edinger M,Myles J et al.Flow cytometric immunophenotyping of non-Hodgkin's lymphomas and related disorders[J].Cytometry,1996;25(2):113-124.
  • 7韩晓红,石远凯,冯奉仪,梁建明,邱耀,王然.流式细胞术分析肿瘤患者免疫功能变化[J].实用肿瘤杂志,1999,14(5):273-275. 被引量:74
  • 8Datta U,Kaur K,Varma S C et al.Second immune defects in Non-Hldgkin's lymphoma[J].Indian J Med Res,1992;96:91.
  • 9袁鸿英.NK细胞的抗肿瘤作用[J].国外医学:肿瘤学分册,1985,2:82-85.
  • 10郑贤干,江松福,沈志坚,高申孟,张君丽.非霍奇金淋巴瘤患者外周血淋巴细胞亚群分析及临床意义[J].温州医学院学报,2001,31(4):234-235. 被引量:5

二级参考文献23

  • 1马健,王友赤,乔崇年,张桂生.非霍奇金淋巴瘤患者淋巴细胞功能的研究[J].中华血液学杂志,1995,16(2):93-93. 被引量:1
  • 2吕鸣,孔宪涛,李莉,张玲珍,施笑梅,黄隆安.流式细胞术分析非霍奇金淋巴瘤患者细胞免疫功能变化[J].上海医学,1997,20(2):73-75. 被引量:13
  • 3袁鸿英.NK细胞的抗肿瘤作用[J].国外医学:肿瘤学分册,1985,2:82-85.
  • 4[1]No authers listed. American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference: Definitions for sepsis and organ failure and guidelines for the use of innovative therapies sepsis[J].Crit Care Med,1992,20:864-874
  • 5[2]Bone RC,Balk RA,Cerra FB,et al. Definition for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine[J].Chest,1992,101:1644-1655
  • 6[3]Davics MG,Hagen PO. Systemic inflammatory response synd-rome[J].Br J Surg,1997,84:920-935
  • 7[4]Bone RC. Immunologic dissonance:a continuing evolution in our understanding of the systemic inflammatory responsc syndrome(SIRS)and the multiplc organ dysfunction syndrome[J].Ann Intern Med,1996,125:680-687
  • 8[5]Dofferhoff AS,Bom VJ,de Vries-Hospers HG,et al. Patterns of cytokines, plasma endotoxin, plasminogen activator inhibitor, and actue-phase proteins during the treatment of severe sepsis in humans[J].Crit Care Med,1992,20:185-192
  • 9[6]Reinhart K,Weigand-Lohnert C,Grimminger F,et al.Assessment of the safety and efficacy of the monoclonal anti-tumor necrosis factor antibody-fragment,MAK 195F,in patients with sepsis and septic shock:a multicenter,randomized,placebo controlled,dose-ranging study[J].Crit Care Med,1996,24:733-742
  • 10[7]Starnes HF,Pearec MK,Tewari A,et al.Anti-IL-6 monoelonal antibodies protect against Lethal Escherichia coli infection and leathal tumor necrosis factor alpha challenge in mice[J].J Immunol,1990,145:4185-4191

共引文献89

同被引文献185

引证文献26

二级引证文献126

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部